2aiy
From Proteopedia
| Line 5: | Line 5: | ||
==Overview== | ==Overview== | ||
| - | Crystallographic and NMR studies of insulin have revealed a highly, flexible molecule with a range of different aggregation and structural, states; the importance of these states for the function of the hormone is, still unclear. To address this question, we have studied the solution, structure of the insulin R6 symmetric hexamer using NMR spectroscopy., Structure determination of symmetric oligomers by NMR is complicated due, to 'symmetry ambiguity' between intra- and intermonomer NOEs, and between, different classes of intermonomer NOEs. Hence, to date, only two symmetric, tetramers and one symmetric pentamer (VTB, B subunit of verotoxin) have, been solved by NMR: there has been no other symmetric hexamer or, higher-order oligomer. Recently, we reported a solution structure for R6, ... | + | Crystallographic and NMR studies of insulin have revealed a highly, flexible molecule with a range of different aggregation and structural, states; the importance of these states for the function of the hormone is, still unclear. To address this question, we have studied the solution, structure of the insulin R6 symmetric hexamer using NMR spectroscopy., Structure determination of symmetric oligomers by NMR is complicated due, to 'symmetry ambiguity' between intra- and intermonomer NOEs, and between, different classes of intermonomer NOEs. Hence, to date, only two symmetric, tetramers and one symmetric pentamer (VTB, B subunit of verotoxin) have, been solved by NMR: there has been no other symmetric hexamer or, higher-order oligomer. Recently, we reported a solution structure for R6, insulin hexamer. However, in that study, a crystal structure was used as a, reference to resolve ambiguities caused by the threefold symmetry; the, same method was used in solving VTB. Here, we have successfully, recalculated R6 insulin using the symmetry-ADR method, a computational, strategy in which ambiguities are resolved using the NMR data alone. Thus, the obtained structure is a refinement of the previous R6 solution, structure. Correlated motions in the final structural ensemble were, analysed using a recently developed principal component method; this, suggests the presence of two major conformational substates. The study, demonstrates that the solution structure of higher-order symmetric, oligomers can be determined unambiguously from NMR data alone, using the, symmetry-ADR method. This success bodes well for future NMR studies of, higher-order symmetric oligomers. The correlated motions observed in the, structural ensemble suggest a new insight into the mechanism of phenol, exchange and the T6 <--> R6 transition of insulin in solution. |
==About this Structure== | ==About this Structure== | ||
| - | 2AIY is a | + | 2AIY is a [http://en.wikipedia.org/wiki/Protein_complex Protein complex] structure of sequences from [http://en.wikipedia.org/wiki/ ] with IPH as [http://en.wikipedia.org/wiki/ligand ligand]. Structure known Active Sites: ZN1 and ZN2. Full crystallographic information is available from [http://ispc.weizmann.ac.il/oca-bin/ocashort?id=2AIY OCA]. |
==Reference== | ==Reference== | ||
| Line 22: | Line 22: | ||
[[Category: hormone]] | [[Category: hormone]] | ||
| - | ''Page seeded by [http://ispc.weizmann.ac.il/oca OCA ] on | + | ''Page seeded by [http://ispc.weizmann.ac.il/oca OCA ] on Mon Nov 5 13:19:24 2007'' |
Revision as of 11:14, 5 November 2007
|
R6 HUMAN INSULIN HEXAMER (SYMMETRIC), NMR, 20 STRUCTURES
Overview
Crystallographic and NMR studies of insulin have revealed a highly, flexible molecule with a range of different aggregation and structural, states; the importance of these states for the function of the hormone is, still unclear. To address this question, we have studied the solution, structure of the insulin R6 symmetric hexamer using NMR spectroscopy., Structure determination of symmetric oligomers by NMR is complicated due, to 'symmetry ambiguity' between intra- and intermonomer NOEs, and between, different classes of intermonomer NOEs. Hence, to date, only two symmetric, tetramers and one symmetric pentamer (VTB, B subunit of verotoxin) have, been solved by NMR: there has been no other symmetric hexamer or, higher-order oligomer. Recently, we reported a solution structure for R6, insulin hexamer. However, in that study, a crystal structure was used as a, reference to resolve ambiguities caused by the threefold symmetry; the, same method was used in solving VTB. Here, we have successfully, recalculated R6 insulin using the symmetry-ADR method, a computational, strategy in which ambiguities are resolved using the NMR data alone. Thus, the obtained structure is a refinement of the previous R6 solution, structure. Correlated motions in the final structural ensemble were, analysed using a recently developed principal component method; this, suggests the presence of two major conformational substates. The study, demonstrates that the solution structure of higher-order symmetric, oligomers can be determined unambiguously from NMR data alone, using the, symmetry-ADR method. This success bodes well for future NMR studies of, higher-order symmetric oligomers. The correlated motions observed in the, structural ensemble suggest a new insight into the mechanism of phenol, exchange and the T6 <--> R6 transition of insulin in solution.
About this Structure
2AIY is a Protein complex structure of sequences from [1] with IPH as ligand. Structure known Active Sites: ZN1 and ZN2. Full crystallographic information is available from OCA.
Reference
Unraveling the symmetry ambiguity in a hexamer: calculation of the R6 human insulin structure., O'Donoghue SI, Chang X, Abseher R, Nilges M, Led JJ, J Biomol NMR. 2000 Feb;16(2):93-108. PMID:10723989
Page seeded by OCA on Mon Nov 5 13:19:24 2007
